JEFF GEHLHAUSEN, MD, PHD
Dermatology Physician in NEW HAVEN, Connecticut. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.
What stands out: JEFF GEHLHAUSEN, MD, PHD reported a CMS MIPS final score of 73.5637 out of 100, below the 83.1 national average, and filed 920 Medicare Part D claims in 2023. Every figure on this page comes straight from federal CMS records, with no proprietary rating applied.
JEFF GEHLHAUSEN, MD, PHD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
JEFF GEHLHAUSEN, MD, PHD at a glance
Below national averagePrimary specialty
Medicare Part D claims
MIPS final score
Specialty distribution in Connecticut
How Dermatology Physician compares to other specialties among Connecticut providers
Dermatology Physician share within Connecticut
Dermatology Physician is one of the more visible NUCC categories in Connecticut
Each bar reflects the share of in-state providers whose primary NUCC taxonomy matches the specialty. Long tail of ~690 NUCC codes folded into "Other" to keep the comparison legible.
Medicare quality performance — MIPS
JEFF GEHLHAUSEN, MD, PHD's 2023 MIPS final score plotted against the Dermatology Physician national average
- MIPS Final Score
- 73.5637/100
- vs 83.1 national avg · 2023 performance year
MIPS final score (Dermatology Physician) — 73.5637/100 vs national avg 83.1
Quality benchmarks
- National MIPS avg 2023 reporting year
- Quality dim CMS Quality category
- Cost dim CMS Cost category
- Specialty volume Dermatology Physician US NPIs
73.5637/100 MIPS final score — 9.5 pts below the 83.1 national average
Quality, Cost, Promoting Interoperability, and Improvement Activities composite score for the 2023 performance year. Specialty: Dermatology Physician. Quality dim: 75.8435. Cost dim: 51.4318.
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
JEFF GEHLHAUSEN, MD, PHD is a Dermatology Physician provider practicing in NEW HAVEN, Connecticut, according to the CMS National Plan and Provider Enumeration System (NPPES). Credentials: MD, PHD. NPI: 1992231302. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.
JEFF GEHLHAUSEN, MD, PHD appears in the CMS NPPES registry as a Dermatology Physician provider holding MD, PHD credentials at 2 CHURCH ST S STE 305, NEW HAVEN, CT, 06519, with a listed phone of (203) 785-4445. NPI 1992231302 was issued on 05/04/2017. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what GEHLHAUSEN most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.
Medicare Part D records for calendar year 2023 show 920 prescription claims written by this provider, covering 209 Medicare beneficiaries and totaling roughly $1.5 million in drug spend, split 18% brand-name and 82% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 73.5637/100 for the 2023 performance year (Quality 75.8435, Cost 51.4318), compared with the national average of 83.1.
Dermatology Physician is a mid-sized specialty nationwide, with 14,610 enrolled providers across 53 states and an average of 729 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1992231302 |
|---|---|
| Specialty | Dermatology Physician |
| Credentials | MD, PHD |
| Gender | Male |
| NPI Issued | 05/04/2017 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm JEFF GEHLHAUSEN, MD, PHD's current license status, disciplinary history, and board certifications with the Connecticut Department of Public Health in Connecticut before relying on this page for a clinical or care decision.
How we sourced this profile
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
Reporting: Group practice
Hospital and facility affiliations
Facilities where JEFF GEHLHAUSEN, MD, PHD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Industry payments received (2024) — CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for JEFF GEHLHAUSEN, MD, PHD. Source: openpaymentsdata.cms.gov.
Total received
$130
Largest payer
Janssen Biotech, Inc.
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
Brand vs generic prescribing mix · Typical
18% brand-name claims vs 82% generic, on 920 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
Prescribing Breakdown
- 30-Day Fills
- 1,061
- Total Day Supply
- 28,195
- Brand vs Generic
- 18% brand / 82% generic
- Brand Drug Cost
- $1.5M
- Generic Drug Cost
- $62K
- Antibiotic Claims
- 33
Patient Demographics
- Average Patient Age
- 70.3 years
- Avg HCC Risk Score
- 1.51
- Gender Split
- 49% female / 51% male
- Age Distribution
- <65: 40, 65-74: 93, 75-84: 52, 85+: 24
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
| Drug | Claims |
|---|---|
| Triamcinolone Acetonide | 117 |
| Clobetasol Propionate | 91 |
| Ketoconazole | 80 |
| Tacrolimus | 68 |
| Hydrocortisone | 65 |
| Octagam Immun Globg(Igg)/Malt/Iga Ov50 | 41 |
| Dapsone | 30 |
| Fluconazole | 28 |
| Dupixent Pen Dupilumab | 27 |
| Gabapentin | 27 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Dermatology Physician Overview
How JEFF GEHLHAUSEN, MD, PHD fits within the Dermatology Physician landscape nationally.
JEFF GEHLHAUSEN, MD, PHD's 920 claims are above the specialty average of 729.
Nearby Dermatology Physician Providers in Connecticut
Other clinicians with the same primary specialty enrolled in Connecticut, drawn from the same CMS NPPES roster as GEHLHAUSEN.
Compare Dermatology Physician nationally: see state-by-state distribution →
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
Explore Connecticut
Frequently Asked Questions
What is JEFF GEHLHAUSEN, MD, PHD's specialty? ▼
How much does JEFF GEHLHAUSEN, MD, PHD prescribe under Medicare Part D? ▼
What is JEFF GEHLHAUSEN, MD, PHD's Medicare quality score? ▼
Where is JEFF GEHLHAUSEN, MD, PHD located? ▼
What is JEFF GEHLHAUSEN, MD, PHD's NPI number? ▼
Does JEFF GEHLHAUSEN, MD, PHD prescribe more brand-name or generic drugs? ▼
How many Dermatology Physician providers are there in the US? ▼
What drugs does JEFF GEHLHAUSEN, MD, PHD prescribe most often? ▼
Does JEFF GEHLHAUSEN, MD, PHD accept Medicare? ▼
How can I verify JEFF GEHLHAUSEN, MD, PHD's credentials? ▼
Data Sources
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology